Cytek Biosciences, Inc. CTKB Operating Lease Liability Payments - 2026 (Lessee)
Operating Lease Liability Payments - 2026 (Lessee) at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s operating lease liability payments - 2026 (lessee).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s operating lease liability payments - 2026 (lessee)?
- Cytek Biosciences, Inc. (CTKB) reported operating lease liability payments - 2026 (lessee) of $1.83M in Q1 2026.
- What does operating lease liability payments - 2026 (lessee) mean?
- This represents the specific cash outflow commitment for operating leases scheduled for the calendar year 2026. It allows investors to isolate the impact of real estate and equipment lease obligations on the company's cash flow in a specific future period.